Cancer Biomarkers
A section of Cancers (ISSN 2072-6694).
Section Information
In the current era of precision medicine, cancer biomarkers provide critical data for predicting responses to therapies, generating prognoses of disease outcomes, and in determining oncogenic risk. Biomarkers are increasingly important as companions for drug discovery and development, and can help guide clinical decision-making. This section of Cancers aims to rapidly publish contributions on all aspects of Cancer Biomarkers. We encourage the submission of manuscripts that provide novel biomarkers, systematic reviews, and papers that report significant advances in cancer biomarkers. Topics include, but are not limited to:
- Genomic signatures
- RNA biomarkers
- miRNA biomarkers
- DNA biomarkers
- Protein biomarkers
- Metabolomic biomarkers
- Mutational biomarkers
- Circulating tumor cell (CTC) biomarkers
- Cellular biomarkers
- Imaging biomarkers
- Clinical biomarkers
- Biomarkers of drug response
- Biomarkers of genetic predisposition to cancer
- Biomarkers of cancer outcomes
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Soft Tissue and Bone Sarcoma (Deadline: 30 April 2024)
- 2nd Edition: Minimal Residual Disease of Cancers (Deadline: 30 April 2024)
- Novel Prognostic Biomarkers in Human Cancers: From Discovery to Application (Deadline: 15 May 2024)
- Feature Papers in Section "Cancer Biomarkers" in 2023–2024 (Deadline: 31 May 2024)
- Development, Validation and Application of Advanced Biomarkers in Cerebral Tumours (Deadline: 31 May 2024)
- Circulating Cancer Biomarkers: Progress, Challenges and Opportunities (Deadline: 31 May 2024)
- Breast Cancer Biomarkers and Clinical Translation (Deadline: 31 May 2024)
- Predictive Biomarkers for Lung Cancer (Deadline: 31 May 2024)
- Chronic Lymphocytic Leukemia: Identification of Novel Prognostic Markers and Their Clinical Application (Deadline: 10 June 2024)
- Biomarkers in Prostate Cancers (Deadline: 15 June 2024)
- Ovarian Cancer Proliferation and Progression (Deadline: 20 June 2024)
- Predictive Biomarkers for Colorectal Cancer (Deadline: 21 June 2024)
- New Approaches in Leukemia (Deadline: 30 June 2024)
- Biomarkers for the Early Detection and Treatment of Cancers (Deadline: 30 June 2024)
- Liquid Biopsy for Lung Cancer Treatment (Deadline: 30 July 2024)
- Biomarkers for Treatment Prediction, Prognosis and Early Detection of Gynecologic Cancer (Deadline: 15 August 2024)
- Biomarkers in Breast Cancer: Recent Advances and Challenges (Deadline: 30 August 2024)
- New Advances in Urothelial Cancer: Diagnosis, Therapy and Prognosis (Deadline: 13 September 2024)
- The Estrogen Receptor and Its Role in Cancer (Deadline: 15 September 2024)
- Current and Emerging Utility of Liquid Biopsy in Cancers: More than Surrogate Biomarkers (2nd Edition) (Deadline: 20 September 2024)
- Pre-clinical Studies of Personalized Medicine for Cancer Research (Deadline: 30 September 2024)
- Targets and Biomarkers in Cutaneous Lymphoma (Deadline: 30 September 2024)
- Imaging and Molecular Biology as Biomarkers for Lung Cancer (Deadline: 30 September 2024)
- Biomarker in Urologic Cancer (Deadline: 30 September 2024)
- Novel Biomarkers in Non-small Cell Lung Cancer (NSCLC) (Deadline: 30 September 2024)
- Novel Diagnostic and Therapeutic Approaches in Diffuse Gliomas (Deadline: 15 October 2024)
- Genome Sequencing of Cancer: Identifying Targets and Biomarkers for Therapy (Deadline: 25 October 2024)
- Head and Neck Cancers—Novel Approaches and Future Outlook (Deadline: 31 October 2024)
- Cancer Biomarkers: Recent Progress, Innovations and Future Clinical Implications (Deadline: 15 November 2024)
- Novel Biomarkers of Hepatobiliary Tumors (Deadline: 30 November 2024)
- miRNA in Colorectal Cancer (Deadline: 30 November 2024)
- Possible Biomarkers in Oral Tumors and Their Clinical Significance (Deadline: 30 November 2024)
- Liquid Biopsy in Breast Cancer (Volume II) (Deadline: 15 December 2024)
- New Biomarkers in Cancers (Volume II) (Deadline: 15 December 2024)
- Brain Tumours: Advances in Imaging-Guided Diagnosis, Surveillance and Therapy (Deadline: 20 December 2024)
- The Role of Genes in Prostate Cancer (Deadline: 25 December 2024)
- PTEN: Regulation, Signalling and Targeting in Cancer (Deadline: 31 December 2024)
- Cancer Biomarkers—Detection and Evaluation of Response to Therapy (Deadline: 30 June 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Cancer Radiotherapy
- Biomarkers for Detection and Prognosis of Prostate Cancer
- Biomarkers of Thyroid Cancer
- Cancer Biomarkers
- Cancer Biomarkers in Body Fluids
- Imaging Biomarker in Oncology
- The Biomarkers for the Diagnosis and Prognosis in Cancer
- The Molecular Predictive and Prognostic Biomarkers in Breast Cancer
- The Role of Non-coding RNA in Cancer
